NAGA and tuberculosis: Given NagA’s crucial role in cell wall and biofilm formation, the development of NagA inhibitors combined with molecules that exploit the defective cell envelope or exhibit increased efficacy in the presence of defective biofilms could enhance the effectiveness of TB therapy, opening new avenues to explore to combat this major global pathogen.